| Dr Lyle Eugene Woerth, MD | |
|
2900 S 70th St Ste 450, Lincoln, NE 68506-3796 | |
| (402) 489-4186 | |
| (402) 489-5279 |
| Full Name | Dr Lyle Eugene Woerth |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 2900 S 70th St Ste 450, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366462731 | NPI | - | NPPES |
| 47060018713 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 17043 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryan Medical Center | Lincoln, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Anesthesiologists, Pc | 4385630391 | 85 |
News Archive
Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."
Cancer patients, with their weakened immune systems, are particularly vulnerable when the cold and flu season hits. The National Cancer Institute (NCI), part of the National Institutes of Health and the world's most prestigious cancer research body, is sponsoring a landmark trial to evaluate if a unique Canadian cold remedy - ginseng extract COLD-FX - can help.
Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston School of Public Health.
Smoking cannabis which has previously been shown to damage mental health, now according to a new study may be useful in relieving the symptoms of severe mental illnesses such as bipolar disorder.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
› Verified 4 days ago
| Entity Name | Associated Anesthesiologists, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972674604 PECOS PAC ID: 4385630391 Enrollment ID: O20040423001226 |
News Archive
Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."
Cancer patients, with their weakened immune systems, are particularly vulnerable when the cold and flu season hits. The National Cancer Institute (NCI), part of the National Institutes of Health and the world's most prestigious cancer research body, is sponsoring a landmark trial to evaluate if a unique Canadian cold remedy - ginseng extract COLD-FX - can help.
Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston School of Public Health.
Smoking cannabis which has previously been shown to damage mental health, now according to a new study may be useful in relieving the symptoms of severe mental illnesses such as bipolar disorder.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lyle Eugene Woerth, MD 2900 S 70th St Ste 450, Lincoln, NE 68506-3796 Ph: (402) 489-4186 | Dr Lyle Eugene Woerth, MD 2900 S 70th St Ste 450, Lincoln, NE 68506-3796 Ph: (402) 489-4186 |
News Archive
Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."
Cancer patients, with their weakened immune systems, are particularly vulnerable when the cold and flu season hits. The National Cancer Institute (NCI), part of the National Institutes of Health and the world's most prestigious cancer research body, is sponsoring a landmark trial to evaluate if a unique Canadian cold remedy - ginseng extract COLD-FX - can help.
Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston School of Public Health.
Smoking cannabis which has previously been shown to damage mental health, now according to a new study may be useful in relieving the symptoms of severe mental illnesses such as bipolar disorder.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
› Verified 4 days ago
Dr. Rebecca Eileen Christensen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-434-5600 Fax: 402-434-5601 | |
Dr. Chad Alan Ott, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2900 S 70th St Ste 450, Lincoln, NE 68506 Phone: 402-489-4186 Fax: 402-489-5279 | |
Charles D Gregorius, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6911 Van Dorn St, Suite 2, Lincoln, NE 68506 Phone: 402-489-4186 Fax: 402-489-5279 | |
Dr. John Richard Knudsen, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-434-5600 | |
Ricky Gene Hartwig, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1730 S 70th St, Lincoln, NE 68506 Phone: 402-423-7774 Fax: 402-423-7774 | |
Mr. Jeff J Swanson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 575 S 70th St Ste 305, Lincoln, NE 68510 Phone: 402-434-5600 Fax: 402-434-5601 | |
Christopher S Cuciti, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6911 Van Dorn St, Suite 2, Lincoln, NE 68506 Phone: 402-489-4186 Fax: 402-489-5279 |